Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125143132 | 12514313 | 2 | F | 20150206 | 20160816 | 20160630 | 20160825 | EXP | US-JNJFOC-20160523060 | JANSSEN | 80.29 | YR | E | F | Y | 79.92000 | KG | 20160825 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125143132 | 12514313 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 20 | MG | TABLET | ||||||
| 125143132 | 12514313 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 0 | 20 | MG | TABLET | ||||||
| 125143132 | 12514313 | 3 | PS | XARELTO | RIVAROXABAN | 1 | Oral | N | UNKNOWN | 202439 | 20 | MG | TABLET | ||||||
| 125143132 | 12514313 | 4 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | 0 | 75 | MG | UNSPECIFIED | ||||||||
| 125143132 | 12514313 | 5 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | UNSPECIFIED | QD | |||||||
| 125143132 | 12514313 | 6 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
| 125143132 | 12514313 | 7 | C | ULTRAM | TRAMADOL HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | TABLETS |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125143132 | 12514313 | 1 | Atrial fibrillation |
| 125143132 | 12514313 | 2 | Thrombosis prophylaxis |
| 125143132 | 12514313 | 3 | Cerebrovascular accident prophylaxis |
| 125143132 | 12514313 | 4 | Product used for unknown indication |
| 125143132 | 12514313 | 5 | Product used for unknown indication |
| 125143132 | 12514313 | 6 | Product used for unknown indication |
| 125143132 | 12514313 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125143132 | 12514313 | HO |
| 125143132 | 12514313 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125143132 | 12514313 | Epistaxis | |
| 125143132 | 12514313 | Fall | |
| 125143132 | 12514313 | Haemorrhage intracranial |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125143132 | 12514313 | 1 | 20150116 | 20150307 | 0 | |
| 125143132 | 12514313 | 2 | 20150116 | 20150307 | 0 | |
| 125143132 | 12514313 | 3 | 20150116 | 20150307 | 0 |